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Simple Summary: Despite political efforts across the world and Europe, social inequalities in cancer
incidence are persistent. We studied the association between socioeconomic status (SES) and cancer
incidence in nine Spanish provinces. Lower SES was associated with an increased risk of lung cancer
among males. Higher SES was associated with an increased risk of breast cancer among females
in Spain. Understanding the reasons behind the association between cancer incidence and SES
could help develop appropriate public health programs to promote health and reduce socioeconomic
inequalities in cancer incidence in Spain.
Abstract: Socioeconomic inequalities in cancer incidence are not well documented in southern Europe.
We aim to study the association between socioeconomic status (SES) and colorectal, lung, and breast
cancer incidence in Spain. We conducted a multilevel study using data from Spanish population-
based cancer registries, including incident cases diagnosed for the period 2010–2013 in nine Spanish
provinces. We used Poisson mixed-effects models, including the census tract as a random intercept,
to derive cancer incidence rate ratios by SES, adjusted for age and calendar year. Male adults with
the lowest SES, compared to those with the highest SES, showed weak evidence of being at increased
risk of lung cancer (risk ratio (RR): 1.18, 95% CI: 0.94–1.46) but showed moderate evidence of being
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at reduced risk of colorectal cancer (RR: 0.84, 95% CI: 0.74–0.97). Female adults with the lowest SES,
compared to those with the highest SES, showed strong evidence of lower breast cancer incidence
with 24% decreased risk (RR: 0.76, 95% CI: 0.68–0.85). Among females, we did not find evidence of
an association between SES and lung or colorectal cancer. The associations found between SES and
cancer incidence in Spain are consistent with those obtained in other European countries.
Keywords: socioeconomic inequalities; colorectal cancer; lung cancer; breast cancer; epidemiology;
population-based study
1. Introduction
The burden of cancer is rising globally, exerting a significant strain on populations
and health systems at all income levels. Given the sociodemographic change in Western
societies, cancer control will be one of the most complex health challenges in the future [1].
Estimates of population-based cancer incidence serve to evaluate cancer’s burden on
health systems worldwide [2]. Despite political efforts across the world and Europe,
social inequalities in cancer incidence are a persistent problem [3]. Social inequalities
in cancer outcomes have an economic impact on healthcare costs [4]. Thus, identifying
and characterizing socioeconomic and geographic disparities in cancer outcomes helps
optimize and redistribute healthcare services in a more equitable fashion.
In northern Europe, there is a long-standing tradition of measuring deprivation
in small geographical areas but not in Spain [5]. Recently, a standardized measure of
socioeconomic deprivation covering Spain’s whole territory has been developed using the
national census data from 2011, namely, the Spanish Deprivation Index (SDI). The index
allows one to characterize and compare socioeconomic inequalities in cancer outcomes as a
function of census tracts [6].
Using this newly developed index, we aim to study the association between socioeco-
nomic inequalities and cancer incidence for three anatomical sites from the European High
Resolution Studies [7] (i.e., colorectal, lung, and breast cancers) in Spain. Furthermore,
we aim to investigate how cancer incidence varies geographically in small areas after
accounting for age and the SDI in Spain during the period 2010–2013.
2. Materials and Methods
2.1. Study Design, Participants, Data, and Setting
We developed a population-based multilevel study. Data were drawn from nine
Spanish population-based cancer registries (Albacete, Bizkaia, Castellón, Cuenca, Girona,
Gipuzkoa, Granada, Navarra, and Tarragona) that participated in the European High
Resolution Studies (TRANSCAN-HIGHCARE project within ERA-Net) [7]. Supplementary
Figure S1 shows the location, within peninsular Spain, of the nine provinces of the study.
Colorectal, lung, and breast cancer cases >18 years and diagnosed during the period 2010–
2013 by census tract level, including their age, sex, and year of diagnosis, were included in
the study. Case codes were C18–C21 with malignant behavior (/3) for colorectal, C34.0–
C34.9 with malignant behavior (/3) for lung, and C50.0–C50.9 with malignant behavior
(/3) or in situ (/2) for breast cancer among females according to the topography code of
the International Classification of Diseases for Oncology, 3rd Edition [8]. Colorectal cancer
data were used in a previous work to assess socioeconomic inequalities (measured with
SDI) on survival in Spain [9].
Population-based figures broken down by census tract level, age, calendar year, and
sex were obtained from the Spanish Statistical Office. The SDI was created by Duque
et al. [6] using data from the Spanish 2011 census conducted by the Spanish National
Statistics Institute. The index includes information from six indicators mainly related to
employment and education: percentage of manual workers (employed or unemployed),
percentage of occasional workers (employed or unemployed), percentage of the population
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with insufficient education, and percentage of main homes without internet access [6]. The
index has no direct information about income, but in the sensitivity analysis, we found a
direct association between SDI and average income per census tract [10] (Supplementary
Figure S2). We used the SDI divided in quintiles (Q), where Q5 represents the most
deprived areas and Q1 the least deprived areas.
The internal review board of the Andalusian School of Public Health (CP17/00206) and
the biomedical ethics committee of the Department of Health of the Andalusian Regional
Government (study 0072-N-18) approved the study protocol.
2.2. Statistical Analysis
In the descriptive analysis, we first estimated the crude rates per 100,000 people for the
overall period and by the quintiles of deprivation, categories of age, and sex. To compute
the incidence rates, we used the total population at risk for the analyzed period. Afterward,
we computed univariable- and multivariable-adjusted rate ratios using a Poisson mixed-
effects model [11]. Models were stratified by sex. We added one variable at a time to
control for confounding and used robust standard errors to account for overdispersion [12].
The final model was adjusted for SDI quintile, age in years, and calendar year. The model
specification was given by
ln(cases/population) = β0 + β1 × (Quintile SDI) + β2 × (Age) + β3 × (Calendar year) + Q (1)
where Q is the random intercept for census tracts.
We included the census tract as a random intercept (Q in (1)) to account for spatial
heterogeneity. From the models, we derived the Empirical Bayesian Estimate to identify
patterns of non-random variation in cancer incidence in Spain [13]. Using the posterior
Empirical Bayesian prediction, we mapped the age- and SES-standardized cancer incidence
smoothed rates adjusted for the SDI by census tract in Spain for colorectal, lung, and
breast cancers.
We assessed different model specifications in the sensitivity analysis, including the
non-linearity effect of age using restricted cubic splines. Furthermore, we assessed the
consistency of the reported cancer incidence rates by calendar year and cancer registry
with published evidence in official statistical sources [14].
We used Stata v.16.1 (StataCorp, College Station, TX, USA) [15] and R v.4.0.2 (R
Foundation for Statistical Computing, Vienna, Austria) [16] for statistical analysis.
3. Results
Figure 1 shows the SDI quintiles’ spatial distribution in 2011 by census tract for the
nine Spanish provinces under study. Overall, there was a north–south pattern with the
highest deprivation in the southern provinces (Granada, Albacete, and Cuenca) compared
to those in the north of Spain (Bizkaia, Gipuzkoa, Girona, Navarra, and Tarragona). The
province of Castellón showed an intermediate pattern between the northern and southern
provinces. Supplementary Figure S3 shows the spatial distribution of the quintiles of SDI
in the provinces’ capitals.




Figure 1. Quintiles of the Spanish Deprivation Index (SDI) by census tract in the nine Spanish provinces under study, 2011. 
Table 1 shows the total number of cancer cases, the population at risk, and the ob-
served incidence rates per 100,000 people during the period 2010–2013 by cancer site, sex, 
quintiles of deprivation, and age groups. 
Table 1. Cancer incidence, population at risk, incidence rate per 100,000 people, and p-value for trend by sex, deprivation, 
and age groups in Spain for the period 2010–2013. 
 Colorectal Cancer 




Incidence rate * 
(95%CI) 
p-value 
for trend Cases 
Popula-
tion at risk




Overall rate period 
2010–2013 
1457 3,088,569 47.2 (44.8–49.7)  2366 3,058,549 77.4 (74.3–80.5)  
Quintiles of SDI    0.031    0.288 
Q1 306 710,049 43.1 (38.4–48.2)  502 666,960 75.2 (68.8–82.2)  
Q2 300 685,582 43.8 (39.0–49.0)  504 669,303 75.3 (68.9–82.2)  
Q3 341 676,128 50.4 (45.2–56.1)  500 673,987 74.2 (67.8–81.0)  
Q4 273 556,068 49.1 (43.4–55.3)  497 567,003 87.7 (80.1–95.7)  
Q5 237 460,742 51.4 (45.1–58.4)  363 481,296 75.4 (67.8–83.6)  
Age groups    <0.001    <0.001 
<50 91 1,913,857 4.8 (38.3–58.4)  103 2,034,317 5.1 (4.1–6.1)  
Figure 1. Quintiles of the Spanish Deprivation Index (SDI) by census tract in the nine Spanish provinces under study, 2011.
Table 1 shows the total number of cancer cases, the population at risk, and the observed
incidence rates per 100,000 people during the period 2010–2013 by cancer site, sex, quintiles
of deprivation, and age groups.
Table 1. Cancer incidence, population at risk, inci e ce rate er 100,000 people, and p-value for trend by sex, deprivation,
and age roups in Spain for the period 2010–2013.
Col rectal Cancer
Females Males














1457 3,088,569 47.2 (44.8–49.7) 2366 3,058,549 77.4 (74.3–80.5)
Quintiles of
SDI 0.031 0.288
Q1 306 710,049 43.1 (38.4–48.2) 502 666,960 75.2 (68.8–82.2)
Q2 300 685,582 43.8 (39.0–49.0) 504 669,303 75.3 (68.9–82.2)
Q3 341 676,128 50.4 (45.2–56.1) 500 673,987 74.2 (67.8–81.0)
Q4 273 556,068 49.1 (43.4–55.3) 497 567,003 87.7 (80.1–95.7)
Q5 237 460,742 51.4 (45.1–58.4) 363 481,296 75.4 (67.8–83.6)
Age groups <0.001 <0.001
<50 91 1,913,857 4.8 (38.3–58.4) 103 2,034,317 5.1 (4.1–6.1)
50–54 89 209,507 42.5 (34.1–52.3) 110 215,299 51.1 (42.0–61.6)
55–59 123 173,809 70.8 ( 8.8–84.4) 210 172,994 121.4 (105.5–139.0)
60–64 131 161,485 81.1 (67.8–96.3) 280 155,412 180.2 (159.7–202.6)
65–69 183 145,714 125.6 (108.1–145.2) 328 132,958 246.7 (220.7–274.9)
70–74 161 129,505 124.3 (105.9–145.1) 337 109,816 306.9 (275.0–341.5)
75–79 236 137,047 172.2 (150.9–195.7) 416 108,811 382.3 (346.5–420.9)
80–84 240 112,979 212.4 (186.4–241.1) 354 77,129 459.0 (412.4–509.4)
≥85 203 104,666 194.0 (168.2–222.5) 228 51,813 440.0 (384.8–501.0)


















180 1,309,540 13.8 (11.8–15.9) 887 1,294,591 68.5 (64.1–73.2)
Quintiles of
SDI 0.555 0.004
Q1 39 231,526 16.8 (12.0–23.0) 125 211,780 59.0 (49.1–70.3)
Q2 21 230,603 9.1 (5.6–13.9) 144 225,239 63.9 (53.9–75.3)
Q3 47 272,080 17.3 (12.7–23.0) 171 270,082 63.6 (54.2–73.6)
Q4 36 308,654 11.7 (8.2–16.2) 211 311,269 67.8 (59.0–77.6)
Q5 37 266,677 13.9 (9.8–19.1) 236 276,221 85.4 (74.9–97.1)
Age groups <0.001 <0.001
<50 23 843,733 2.7 (1.7–4.1) 36 890,011 4.0 (2.8–5.6)
50–54 34 88,734 38.3 (26.5–53.5) 50 88,958 56.2 (41.7–74.1)
55–59 21 71,940 29.2 (18.1–44.6) 90 71,123 126.5 (101.8–155.5)
60–64 26 65,445 39.7 (26.0–58.2) 99 61,409 161.2 (131.0–196.3)
65–69 12 57,708 20.8 (10.7–36.3) 133 53,024 250.8 (210.0–297.3)
70–74 7 50,656 13.8 (5.6–28.5) 138 42,560 324.3 (272.4–383,1)
75–79 23 53,693 42.8 (27.2–64.3) 163 41,764 390.3 (332.7–455.0)
80–84 17 41,883 40.6 (23.6–65.0) 122 27,786 439.1 (364.6–524.3)
≥85 17 35,748 47.6 (27.7–76.1) 56 17,956 311.9 (235.6–405.0)
Breast Cancer—Females








3157 2,902,468 108.8 (105.0–112.6)
Quintiles of
deprivation <0.001
Q1 721 567,481 127.1 (118.0–136.7)
Q2 631 558,370 113.0 (104.4–122.2)
Q3 571 553,979 103.1 (94.8–111.9)
Q4 629 608,179 103.4 (95.5–111.8)
Q5 605 614,459 98.5 (90.8–106.6)
Age groups <0.001
<50 912 1,839,937 49.6 (46.4–52.9)
50–54 393 193,301 203.3 (183.7–224.4)
55–59 332 165,866 200.2 (179.2–222.9)
60–64 350 153,247 228.4 (205.1–253.6)
65–69 323 133,590 241.8 (216.1–269.6)
70–74 208 112,291 185.2 (160.9–212.2)
75–79 263 117,201 224.4 (198.1–253.2)
80–84 197 95,765 205.7 (178.0–236.5)
≥85 179 91,270 196.1 (168.4–227.1)
* Per 100,000 people.
There were 3823 colorectal cancer cases and 6,147,118 people at risk in seven Spanish
provinces during the period 2010–2013. Males showed a higher crude rate than females
(77.4 per 100,000 males vs. 47.2 per 100,000 females). The crude incidence rate increased
with age for both males and females, and, with quintiles of deprivation, only for females.
Females with colorectal cancer living in the most deprived areas (i.e., Q5) showed 51.4
cases per 100,000 vs. 43.1 cases per 100,000 among females living in the least deprived
areas (i.e., Q1).
There were 1067 lung cancer cases and 2,604,131 people at risk in two Spanish
provinces during 2011–2012. Lung cancer risk increased with age for both males and
females and with quintiles of deprivation only among males. Males with lung cancer living
in the most deprived areas (i.e., Q5) showed a rate of 85.4 cases per 100,000 vs. 59.0 cases
per 100,000 among males living in the least deprived areas (i.e., Q1).
There were 3157 breast cancer cases and 2,902,468 females at risk in six Spanish
provinces during the period 2010–2013. Breast cancer incidence risk increased with age
and decreased with deprivation levels (i.e., women living in the most deprived areas had a
lower breast cancer incidence risk). Females with breast cancer living in the most deprived
areas (i.e., Q5) showed a rate of 98.5 cases per 100,000 vs. 127.1 cases per 100,000 among
females living in the least deprived areas (i.e., Q1).
Table 2 shows the cancer incidence risk by sex, adjusted for deprivation, age, calendar
year, and accounting for the correlation within census tracts for colorectal, lung, and breast
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cancer during the period 2010–2013. After adjusting for age and calendar year (Model 3),
the incidence risk of colorectal cancer among males living in the most deprived areas was
16% lower than for the males with colorectal cancer living in the least deprived areas (i.e.,
incidence rate ratio (IRR) Q5 vs. Q1: 0.84, 95% CI: 0.74–0.97). In females, there was no
evidence of an association between deprivation and colorectal cancer incidence risk. There
was weak evidence of an increased lung cancer incidence risk among the most deprived
males (i.e., IRR Q5 vs. Q1: 1.18, 95% CI: 0.94–1.46) but not among women. For breast cancer,
women from the least deprived areas showed an increased risk compared to women from
the most deprived areas (i.e., IRR Q5 vs. Q1: 0.76, 95% CI: 0.68–0.85).
Table 2. Cancer incidence rates ratios by sex, adjusted for deprivation and age in Spain for the period 2010–2013.
Colorectal Cancer
Females Males
Variables Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI)
Quintiles of SDI
Q1 Ref. Ref. Ref. Ref. Ref. Ref.
Q2 1.02 (0.87–1.20) 1.02 (0.87–1.20) 0.99 (0.84–1.16) 0.98 (0.86–1.12) 0.94 (0.83–1.07) 0.94 (0.83–1.07)
Q3 1.14 (0.98–1.34) 1.15 (0.98–1.34) 1.09 (0.93–1.27) 0.99 (0.87–1.13) 0.93 (0.82–1.05) 0.93 (0.82–1.05)
Q4 1.13 (0.97–1.33) 1.14 (0.97–1.34) 1.04 (0.89–1.22) 1.16 (1.01–1.32) 1.02 (0.90–1.17) 1.03 (0.91–1.18)
Q5 1.16 (0.98–1.38) 1.17 (0.98–1.39) 1.02 (0.86–1.22) 0.99 (0.86–1.14) 0.83 (0.72–0.95) 0.84 (0.74–0.97)
Age in years
Per ten years increase 1.02 (0.95–1.10) 1.03 (0.96–1.11) 1.86 (1.81–1.92) 1.86 (1.81–1.92)
Period 2010–2013
Per one year increase 1.58 (1.53–1.63) 1.10 (1.04–1.16)
Lung Cancer
Females Males
Variables Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI)
Quintiles of SDI
Q1 Ref. Ref. Ref. Ref. Ref. Ref.
Q2 0.56 (0.32–0.97) 0.56 (0.32–0.96) 0.57 (0.33–0.98) 1.06 (0.83–1.36) 1.08 (0.85–1.38) 1.08 (0.85–1.37)
Q3 1.02 (0.66–1.57) 1.01 (0.66–1.56) 1.03 (0.67–1.58) 1.04 (0.83–1.30) 1.07 (0.85–1.34) 1.07 (0.85–1.34)
Q4 0.71 (0.45–1.13) 0.72 (0.45–1.15) 0.72 (0.45–1.14) 1.14 (0.91–1.42) 1.12 (0.90–1.39) 1.12 (0.90–1.39)
Q5 0.80 (0.50–1.28) 0.82 (0.51–1.31) 0.76 (0.47–1.22) 1.37 (1.09–1.71) 1.17 (0.94–1.46) 1.18 (0.94–1.46)
Age in years
Per ten years increase 0.86 (0.62–1.18) 0.85 (0.62–1.17) 2.03 (1.94–2.13) 2.03 (1.94–2.13)
Period 2011–2012
Per one year increase 1.50 (1.40–1.61) 1.00 (0.87–1.15)
Breast Cancer—Females
Variables Model 1 Model 2 Model 3
IRR (95% CI) IRR (95% CI) IRR (95% CI)
Quintiles of SDI
Q1 Ref. Ref. Ref.
Q2 0.90 (0.80–1.00) 0.91 (0.81–1.01) 0.89 (0.80–0.99)
Q3 0.83 (0.74–0.93) 0.84 (0.75–0.94) 0.81 (0.73–0.91)
Q4 0.82 (0.74–0.92) 0.83 (0.74–0.92) 0.79 (0.71–0.89)
Q5 0.79 (0.71–0.88) 0.80 (0.72–0.89) 0.76 (0.68–0.85)
Age in years
Per ten years increase 1.07 (1.03–1.12) 1.06 (1.02–1.11)
Period 2010–2013
Per one year increase 1.42 (1.40–1.44)
IRR: Incidence rate ratio. Model 1: model adjusted for quintiles of the SDI. Model 2: model adjusted for quintiles of the SDI and age. Model
3: model adjusted for quintiles of the SDI, age, and year of diagnosis.
Figures 2–4 show the observed and age- and SES-standardized incidence smoothed
rates by census tracts for colorectal, lung, and breast cancers. The pattern of smoothed rates
for colorectal cancer was characterized by a higher cancer incidence risk in northern Spanish
provinces (i.e., Bizkaia, Girona, and Navarra) than in southern provinces (i.e., Granada and
Albacete) (Figure 2). For lung cancer, Granada showed a higher risk than Girona (Figure 3).
However, for breast cancer, the same north–south pattern was present, showing higher
smoothed incidence rates in the northern provinces (i.e., Gipuzkoa, Navarra, Girona, and
Tarragona) compared to the southern province of Granada (Figure 4). Furthermore, there
was a north–south pattern regarding the spatial heterogeneity of the smoothed rates. The
pattern was characterized by a higher heterogeneity of the rates in northern provinces than
southern provinces except for lung cancer, where Granada showed a homogenous higher
risk than Girona. Overall, for breast and colorectal cancer, the risk was higher in the census
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tracts from the province’s capital (Supplementary Figures S4 and S6), while the opposite
pattern was found for lung cancer (Supplementary Figure S5).









Figure 2. (a) Observed colorectal incidence rates and (b) smoothed cancer incidence rates adjusted for deprivation and age 
by census tract in seven Spanish provinces during the period 2010–2013. 
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Figure 3. (a) Lung observed incidence rates and (b) smoothed cancer incidence rates adjusted for deprivation and age by census tract 
in two Spanish provinces during the period 2011–2012. 
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Figure 4. (a) Breast observed incidence rates and (b) smoothed cancer incidence rates adjusted for deprivation and age by 
census tract in seven Spanish provinces during the period 2010–2013. 
Including the non-linear effect of age did not improve the overall model goodness of 
fit in the sensitivity analyses. Furthermore, the reported incidence rates were consistent 
with previously published evidence from official sources [17]. 
4. Discussion 
We found that males with the lowest SES showed an increased risk of lung cancer 
incidence and a reduced risk of colorectal cancer incidence than those with the highest 
SES. Females with the lowest SES had a reduction in breast cancer incidence. Among 
women, we did not find evidence of an association between SES and lung or colorectal 
cancer. 
Overall, our results are consistent with current evidence from population-based stud-
ies regarding cancer incidence and SES in Europe [18]. Low SES was associated with an 
increased risk of lung cancer in Denmark [19], England [20,21], France [22,23], Germany 
[24–26], Ireland [27], Italy [28], Slovenia [29], Sweden [30], and Scotland [31,32]. We found 
the same result in men, but the risk was not clear in women, perhaps due to the reduced 
number of cases. Furthermore, we found an inverse association between SES and breast 
cancer risk characterized by an increased risk among women with higher SES than those 
with lower SES. Likewise, the same pattern was found in England [21], France [22], Ger-
many [24,25], Ireland [27], Italy [28], Scotland [32], and Slovenia [29]. However, there is a 
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Figure 4. (a) Breast observed incidence rates and (b) smoothed cancer incidence rates adjusted for deprivation and age by
census tract in seven Spanish provinces during the period 2010–2013.
Including the non-linear effect of age did not improve the overall model goodness of
fit in the sensitivity analyses. Furthermore, the reported incidence rates were consistent
with previously published evidence from official sources [17].
4. Discussion
We found that males with the lowest SES showed an increased risk of lung cancer
incidence and a reduced i ca cer incidence than those with the highest SES.
Females with the lowest SES had a reduction in breast cancer i idence. Among women,
we did not find evidenc of a association between SES and lung or colorectal cancer.
Overall, our results are consistent with current evidence from population-based stud-
ies rega ding cancer incidence and SES in Europe [18]. L w SES was associated with
an inc eased risk of lung cancer in De ma k [19], England [20,21], France [22,23], Ger-
many [24–26], Ireland [27], Italy [28], Slovenia [29], Sweden [30], and Scotland [31,32].
We found the same result in men, but the risk was not clear in women, perhaps due to
the reduced numb r of cases. Furthermore, we found an inverse association between
SES and breast cancer isk characterized by an increa ed risk among women with higher
SES than those with lower SES. Likewise, the same pattern was found in England [21],
France [22], Germany [24,25], Ireland [27], Italy [28], Scotla d [32], and Slovenia [29]. How-
ever, there is a varying pattern of colorectal cancer incidence risk in Europe. Low SES
was associated with an increased risk in E gland [21], Germany [25,26], and Scotland [31],
w ile in other European cou tries, th e was a reverse associ tion or no associa ion at
all [18,23,24,27,29,33]. In our study, we found that m les of more deprived areas were at a
lower risk of colorectal cancer. W argue that it might be that there are two distinguished
patte ns l cancer risk in Europe related to lifestyle and cultural risk factors
ssociated with SES [34]. However, more evidence is needed based on large periods and
ampl sizes. Furthermore, differences in the availability and impact of colorect l and
breast cancer regional screen ng programs [35] m ght be associated with differ nces i the
g ographical distribution of cancer incidence rates.
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4.1. Strengths
To the best of our knowledge, this is the first time that the association between
area level SES and cancer incidence has been assessed in several Spanish provinces in a
population-based study. Our study adds evidence regarding socioeconomic inequalities in
cancer incidence around southern Europe. Furthermore, our results are consistent with
other European countries and previous studies from Spain’s northeast region [36].
The number of incident cancer cases reported by calendar year for the majority of
cancer registries was exhaustive. Supplementary Tables S1–S3 show the distribution of
the number of cases by anatomical site, year of diagnosis, and province. In the sensitivity
analysis, we compared the reported incidence rates in our study by province and calendar
year in the period 2011–2013 with official published statistics elsewhere [17]. Our study’s
reported cancer incidence rates were consistent with the European Cancer Information
System [17]. Even if there was no information from all the Spanish provinces in our study,
most of the Spanish population-based cancer registries participated in the study, and the
socioeconomic north–south gradient was well represented.
4.2. Limitations
Individual information on SES is often difficult to obtain due to ethical issues. Usually,
it is not available at the population level, and cancer registries use census tracts and
aggregated deprivation measures. SDI is not used as a proxy of individual SES but a
measure of the contextual effect of living in a census tract with a specific SES. We highlight
the importance of interpreting findings at the population level to minimize ecological fallacy
risk. It has recently been shown that, in England and Wales, the average socioeconomic
status at the area level correlates poorly with the individual SES in higher heterogeneity
areas (i.e., ecological fallacy) [37]. Moreover, in our study, the SDI was derived for 2011,
while cancer incidence is measured for the period 2010–2013. However, evidence shows
that the aggregated measures of socioeconomic inequalities are consistent over time [38].
Finally, we suggest caution in interpreting the spatial patterns we identified. There
is no significant random variability due to the short period under study and the limited
number of cancer cases.
5. Conclusions
The study evaluates the association between socioeconomic inequalities and colorectal,
lung, and breast cancer incidence in nine Spanish provinces during the period 2010–
2013. The findings are consistent with other European countries, showing the association
between socioeconomic inequalities and lung cancer among men and reduced breast
cancer incidence among women with lower SES. Studying the causes of these associations
could help develop appropriate public health programs to promote health and reduce
socioeconomic inequalities in cancer incidence in Spain. Further collaborative studies are
required to update the assessment of socioeconomic inequalities in colorectal, lung, and
breast cancers over time in Spain and to evaluate public health programs.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/cancers13112820/s1, Figure S1: Map of peninsular Spain with the provinces of the study
highlighted by anatomical site: (a) colorectum, (b) lung, (c) breast, Figure S2: Spanish deprivation
index (2011) and average income (in EUR) per person (2015) by census tract in Spain, with generalized
additive model (GAM) smoothing, Figure S3: Quintiles of the Spanish Deprivation Index (SDI) by
census tract in the capitals of the nine Spanish provinces under study, 2011, Figure S4: Colorectal
cancer smoothed cancer incidence rates adjusted for deprivation and age by census tract in the area
of the capital of province in seven Spanish provinces during the period 2010–2013, Figure S5: Lung
cancer smoothed cancer incidence rates adjusted for deprivation and age by census tract in the area
of the capital of province in two Spanish provinces during the period 2011–2012, Figure S6: Breast
cancer smoothed cancer incidence rates adjusted for deprivation and age by census tract in the area
of the capital of province in six Spanish provinces during the period 2010–2013, Table S1: Number of
colorectal cancer cases, population at risk, and crude cancer incidence rates by year of diagnosis and
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province in Spain during the period 2010–2013, Table S2: Number of lung cancer cases, population at
risk, and crude cancer incidence rates by anatomical site, year of diagnosis, and province in Spain
during the period 2011–2012, Table S3: Number of breast cancer cases, population at risk, and crude
cancer incidence rates by anatomical site, year of diagnosis, and province in Spain during the period
2010–2013.
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